Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Now available: CD-ROM of highlights from the XXII Congress of the ESC

Jan. 4, 2001

Gestilab patents compositions protecting against myocardial oxidative stress

Jan. 3, 2001

ETA receptor antagonists in various stages of clinical testing at Icos-Texas Biotechnology

Jan. 2, 2001

HIF-1 gene therapy product in clinical trial at U. of Pittsburgh Medical Center

Jan. 2, 2001

Reformulated sampatrilat shows improved bioavailability in animal model

Dec. 29, 2000

Tanabe Seiyaku claims isoquinoline derivatives with cardiovascular activity

Dec. 27, 2000

Sumitomo discloses thiourea derivatives with ECE-inhibitory activity

Dec. 27, 2000

Myogen and BASF to codevelop BSF-208075

Dec. 27, 2000

Dual inhibitors of ACE/NEP in development at Toa Eiyo

Dec. 22, 2000

Ranolazine enters phase II for CHF

Dec. 22, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...